SARS-CoV-2 (100PFU) was incubated with an equal volume of Pre-IgY, S-2-IgY and Remdesivir in different concentration gradients in VeroE6 cells. The results showed that different doses of S-IgY had an obvious inhibitory effect on the cellular SARS-CoV-2 content (copy number) with EC50 of 27.78 ± 1.54 nM. Remdesivir’s EC50 against SARS-CoV-2 was 3259 ± 159.62 nM,
The inhibitory effect of S-IgY on SARS-Cov-2 replication was 106 times stronger more than that of Remdesivir In vitro (Fig.7.)."
They do not give values for how potent the Pre-IgY immunoglobulin is!
I did read it. There is no control.
"5.2 qRT-PCR
SARS-CoV-2 (100PFU) was incubated with an equal volume of Pre-IgY, S-2-IgY and Remdesivir in different concentration gradients in VeroE6 cells. The results showed that different doses of S-IgY had an obvious inhibitory effect on the cellular SARS-CoV-2 content (copy number) with EC50 of 27.78 ± 1.54 nM. Remdesivir’s EC50 against SARS-CoV-2 was 3259 ± 159.62 nM,
The inhibitory effect of S-IgY on SARS-Cov-2 replication was 106 times stronger more than that of Remdesivir In vitro (Fig.7.)."
They do not give values for how potent the Pre-IgY immunoglobulin is!